LGT Capital Partners LTD. Sells 24,006 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

LGT Capital Partners LTD. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 56,030 shares of the healthcare conglomerate's stock after selling 24,006 shares during the quarter. LGT Capital Partners LTD.'s holdings in UnitedHealth Group were worth $28,343,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $40,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. KeyCorp reissued an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Price Performance

UNH traded up $6.32 on Tuesday, reaching $486.54. The stock had a trading volume of 2,774,916 shares, compared to its average volume of 4,959,555. The firm has a 50-day moving average of $513.21 and a 200-day moving average of $552.69. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $445.04 billion, a price-to-earnings ratio of 31.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.83 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.73%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.